Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,581 to 1,600 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Perspectives on immune checkpoint ligands: expression, regulation, and clinical implications. | BMB Rep | 2021 | 34078531 | PubTator, text mining | PubMed |
| An update on targeted therapies in systemic sclerosis based on a systematic review from the last 3 years. | Arthritis Res Ther | 2021 | 34074331 | PubTator, text mining | PubMed |
| Future Directions in Maintenance Therapy in Multiple Myeloma. | J Clin Med | 2021 | 34073689 | PubTator, text mining | PubMed |
| Regulation of AMPK Activity by CRBN Is Independent of the Thalidomide-CRL4CRBN Protein Degradation Axis. | Pharmaceuticals (Basel) | 2021 | 34073624 | PubTator, text mining | PubMed |
| Targeted Approaches to T-Cell Lymphoma. | J Pers Med | 2021 | 34072040 | PubTator, text mining | PubMed |
| Bruton's Tyrosine Kinase Targeting in Multiple Myeloma. | Int J Mol Sci | 2021 | 34071917 | PubTator, text mining | PubMed |
| Regulation of ClC-2 Chloride Channel Proteostasis by Molecular Chaperones: Correction of Leukodystrophy-Associated Defect. | Int J Mol Sci | 2021 | 34070744 | PubTator, text mining | PubMed |
| Emerging Roles of SKP2 in Cancer Drug Resistance. | Cells | 2021 | 34068643 | PubTator, text mining | PubMed |
| Current Therapy of the Patients with MDS: Walking towards Personalized Therapy. | J Clin Med | 2021 | 34068316 | PubTator, text mining | PubMed |
| Targeting Reactive Oxygen Species Metabolism to Induce Myeloma Cell Death. | Cancers (Basel) | 2021 | 34067602 | PubTator, text mining | PubMed |
| Targeting CDK9 for Anti-Cancer Therapeutics. | Cancers (Basel) | 2021 | 34062779 | PubTator, text mining | PubMed |
| CHL1 deletion is associated with cognitive and language disabilities - Case report and review of literature. | Mol Genet Genomic Med | 2021 | 34056867 | PubTator, text mining | PubMed |
| Selective targeting of non-centrosomal AURKA functions through use of a targeted protein degradation tool. | Commun Biol | 2021 | 34050235 | PubTator, text mining | PubMed |
| Evaluation of the Small-molecule BRD4 Degrader CFT-2718 in Small-cell Lung Cancer and Pancreatic Cancer Models. | Mol Cancer Ther | 2021 | 34045230 | PubTator, text mining | PubMed |
| Identification of Potent, Selective, and Orally Bioavailable Small-Molecule GSPT1/2 Degraders from a Focused Library of Cereblon Modulators. | J Med Chem | 2021 | 34042448 | PubTator, text mining | PubMed |
| A protocol for rapid degradation of endogenous transcription factors in mammalian cells and identification of direct regulatory targets. | STAR Protoc | 2021 | 34041503 | PubTator, text mining | PubMed |
| CDK9: A Comprehensive Review of Its Biology, and Its Role as a Potential Target for Anti-Cancer Agents. | Front Oncol | 2021 | 34041038 | PubTator, text mining | PubMed |
| Rational Design and Synthesis of Novel Dual PROTACs for Simultaneous Degradation of EGFR and PARP. | J Med Chem | 2021 | 34038131 | PubTator, text mining | PubMed |
| Acute pharmacological degradation of Helios destabilizes regulatory T cells. | Nat Chem Biol | 2021 | 34035522 | PubTator, text mining | PubMed |
| Exploiting ubiquitin ligase cereblon as a target for small-molecule compounds in medicine and chemical biology. | Cell Chem Biol | 2021 | 34033753 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=80